Efeito da dose de betabloqueador na mortalidade após síndrome coronária aguda

Sergio Raposeiras-Roubin, Emad Abu-Assi, Berenice Carneiro-Queija, Rafael Cobas-Paz, Lucía Rioboo-Lestón, Cristina García Ridríguez, Cruz Giraldez Lemos, María Blanco Vidal, Beatriz Ogando Guillán, Isabel Pérez Martínez, Emilio Paredes-Galán, Victor Jimenez-Díaz, José Antonio Baz-Alonso, Francisco Calvo-Iglesias, Andrés Iñiguez-Romo
Rev Port Cardiol. 2018;37(3):239-245
Conclusion: No prognostic benefit was found in terms of mortality for high-dose vs. low-dose beta-blockers after na ACS.

Disponível Online:
Português: [Resumo]
English: [AbstractFull textPDF]